ADVFN ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Procaps Group SA (EM)

Procaps Group SA (EM) (PROCF)

0,0251
0,00
(0,00%)
Geschlossen 05 Juli 10:00PM

Procaps Group SA (EM) (PROCF) Aktie

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Premium

Wichtige Statistiken und Details

Current Price
0,0251
( - )
Gebot
0,00
Fragen
0,00
Volumen
18
0,00 Tagesbereich 0,00
0,0003 52-Wochen-Bereich 1,40
Marktkapitalisierung
Handelsende
0,0251
Handelsbeginn
-
Letzte Trade
18
@
0.0251
Letzter Handelszeitpunkt
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
US$ 1.231
Ausgegebene Aktien
2.324.807.296
Dividendenrendite (LTM)
Kurs-Gewinn-Verhältnis
-0,04
Gewinn pro Aktie (EPS)
-0,68
Erlöse (LTM)
373,8M
Nettogewinn (LTM)
-68,3M

Über Procaps Group SA (EM)

Sofgen Pharma S.A., together with its subsidiaries, develops, produces, and markets pharmaceutical solutions in South America, Central America, North America, and Europe. It operates in five segments: NextGel, Procaps Colombia, Central America North (CAN), Central America South and North Andes (CASA... Sofgen Pharma S.A., together with its subsidiaries, develops, produces, and markets pharmaceutical solutions in South America, Central America, North America, and Europe. It operates in five segments: NextGel, Procaps Colombia, Central America North (CAN), Central America South and North Andes (CASAND), and Diabetrics. The company develops and manufactures Softgel and related technologies under the Softigel, Sofgen, Softcaps, and Funtrition brands; and Softgel pharmaceutical products, such as Advil, Apronax Liquidgels, multivitamins, Vitamin D, and Dolex ActivGel. It also formulates, manufactures, and markets branded prescription drugs in therapeutic areas, including feminine care products, pain relief, skin care, digestive health, growth and development, cardiology, vision care, central nervous system, and respiratory; and manufactures and markets personal high-complexity drugs for hospital use comprising antibiotics, blood clot, immunosuppressant, oncology, and analgesics products. In addition, the company develops, manufactures, and markets OTC consumer healthcare products consisting of gastrointestinal, skin care, cough and cold, analgesics, urological, and vitamin, minerals, and supplements, as well as antibiotics, anti-infective, and anti-parasitic. Further, it offers blood glucose meters, telemonitoring, Rx oral anti-diabetics products, insulin delivery systems, and other diabetes solutions; and syringes, double chamber syringes, injection vials, injection ampoules, sterilized powder products, sterile droppers, and lyophilized solid vials. The company was formerly known as Procaps Group S.A. Sofgen Pharma S.A. was founded in 1977 and is based in Luxembourg, Luxembourg. Mehr anzeigen

Sektor
-
Branche
-
Hauptsitz
Luxembourg City, Luxembourg
Gegründet
1977
Procaps Group SA (EM) is listed in the sector of the OTC Markets with ticker PROCF. The last closing price for Procaps (EM) was US$0,03. Over the last year, Procaps (EM) shares have traded in a share price range of US$ 0,0003 to US$ 1,40.

Procaps (EM) currently has 2.324.807.296 shares in issue. The market capitalisation of Procaps (EM) is US$58,35 million. Procaps (EM) has a price to earnings ratio (PE ratio) of -0.04.

PROCF Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10000000CS
4000.02510.02510.02515750.0251CS
12000.02510.02510.00038300.01112529CS
26-1.0049-97.56310679611.031.030.00036620.05436942CS
52-1.3749-98.20714285711.41.40.00036390.178024CS
156-0.9849-97.51485148511.011.60.000321840.87884416CS
260-0.9849-97.51485148511.011.60.000321840.87884416CS

PROCF - Frequently Asked Questions (FAQ)

What is the current Procaps Group SA (EM) share price?
The current share price of Procaps Group SA (EM) is US$ 0,0251
How many Procaps Group SA (EM) shares are in issue?
Procaps Group SA (EM) has 2.324.807.296 shares in issue
What is the market cap of Procaps Group SA (EM)?
The market capitalisation of Procaps Group SA (EM) is USD 58,35M
What is the 1 year trading range for Procaps Group SA (EM) share price?
Procaps Group SA (EM) has traded in the range of US$ 0,0003 to US$ 1,40 during the past year
What is the PE ratio of Procaps Group SA (EM)?
The price to earnings ratio of Procaps Group SA (EM) is -0,04
What is the cash to sales ratio of Procaps Group SA (EM)?
The cash to sales ratio of Procaps Group SA (EM) is 0,16
What is the registered address of Procaps Group SA (EM)?
The registered address for Procaps Group SA (EM) is 9 Rue de Bitbourg, Luxembourg City, 1273
What is the Procaps Group SA (EM) website address?
The website address for Procaps Group SA (EM) is www.sofgenpharma.com

PROCF Trades

Mehr

Trades verzögert

Um Echtzeit-Trades zu erhalten, aktualisieren Sie Ihr Konto

Auf Echtzeit aktualisieren
Keine Diskussionen Gefunden.
Neuen Thread Erstellen